{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:58:59Z","timestamp":1788026339577,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/med.0b013e32834ed61f","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T15:56:52Z","timestamp":1377878212000},"page":"57-62","source":"Crossref","is-referenced-by-count":15,"title":["Inflammatory cytokines and growth in childhood"],"prefix":"10.1097","volume":"19","author":[{"given":"Maria L.","family":"Marcovecchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Mohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20211004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000328119","article-title":"Endocrine regulation of longitudinal bone growth.","volume":"21","author":"Wit","year":"2011","journal-title":"Endocr Dev"},{"issue":"Suppl 3","key":"R2-13-20211004","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/MPG.0b013e3181f7feef","article-title":"Inflammation and growth.","volume":"51","author":"Simon","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R3-13-20211004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrgastro.2009.124","article-title":"Mechanisms of growth impairment in pediatric Crohns disease.","volume":"6","author":"Walters","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-13-20211004","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ibd.21214","article-title":"Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height z-score.","volume":"16","author":"Lee","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R5-13-20211004","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ibd.20115","article-title":"Growth retardation in pediatric Crohns disease: pathogenesis and interventions.","volume":"13","author":"Shamir","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 3","key":"R6-13-20211004","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/MPG.0b013e3181f8419f","article-title":"Nutrition and growth in inflammatory bowel disease.","volume":"51","author":"Shamir","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R7-13-20211004","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/ajg.2010.20","article-title":"Nutritional status and growth in pediatric Crohns disease: a population-based study.","volume":"105","author":"Vasseur","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R8-13-20211004","doi-asserted-by":"crossref","first-page":"958915","DOI":"10.1155\/2010\/958915","article-title":"Assessment of growth disturbance in japanese children with IBD.","volume":"2010","author":"Shono","year":"2010","journal-title":"Int J Pediatr"},{"key":"R9-13-20211004","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2008.12.017","article-title":"A two-year longitudinal study of persistent lean tissue deficits in children with Crohns disease.","volume":"7","author":"Sylvester","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-13-20211004","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2011.04.012","article-title":"Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation.","volume":"159","author":"Padeh","year":"2011","journal-title":"J Pediatr"},{"key":"R11-13-20211004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1469-1809.2010.00606.x","article-title":"Association of linear growth impairment in pediatric Crohns disease and a known height locus: a pilot study.","volume":"74","author":"Lee","year":"2010","journal-title":"Ann Hum Genet"},{"key":"R12-13-20211004","first-page":"104","article-title":"Growth in juvenile idiopathic arthritis: the role of inflammation.","volume":"29","author":"Gaspari","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R13-13-20211004","first-page":"1011","article-title":"Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases (review).","volume":"18","author":"MacRae","year":"2006","journal-title":"Int J Mol Med"},{"key":"R14-13-20211004","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ibd.20069","article-title":"Linear growth improves during infliximab therapy in children with chronically active severe Crohns disease.","volume":"13","author":"Walters","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R15-13-20211004","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3899\/jrheum.080199","article-title":"Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis.","volume":"35","author":"Souza","year":"2008","journal-title":"J Rheumatol"},{"key":"R16-13-20211004","first-page":"159","article-title":"Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease.","volume":"61","author":"Street","year":"2004","journal-title":"Horm Res"},{"key":"R17-13-20211004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2010.04.044","article-title":"Determinants of changes in linear growth and body composition in incident pediatric Crohns disease.","volume":"139","author":"Thayu","year":"2010","journal-title":"Gastroenterology"},{"key":"R18-13-20211004","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1073\/pnas.0503589102","article-title":"Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6GC polymorphism in children.","volume":"102","author":"Sawczenko","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-13-20211004","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1572-0241.2005.41737.x","article-title":"TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohns disease.","volume":"100","author":"Levine","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R20-13-20211004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/kei091","article-title":"The pathophysiology of the growth plate in juvenile idiopathic arthritis.","volume":"45","author":"MacRae","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R21-13-20211004","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2265.2010.03799.x","article-title":"The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation.","volume":"73","author":"Wong","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R22-13-20211004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cbf.1551","article-title":"Inflammatory cytokines and the GHIGF-I axis: novel actions on bone growth.","volume":"27","author":"Pass","year":"2009","journal-title":"Cell Biochem Funct"},{"key":"R23-13-20211004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/JOE-10-0045","article-title":"The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins.","volume":"206","author":"Ahmed","year":"2010","journal-title":"J Endocrinol"},{"key":"R24-13-20211004","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0016-5085(00)70260-5","article-title":"The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis.","volume":"118","author":"Ballinger","year":"2000","journal-title":"Gastroenterology"},{"key":"R25-13-20211004","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1365-2265.1998.00562.x","article-title":"Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohns disease.","volume":"49","author":"Beattie","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R26-13-20211004","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005176-200403000-00007","article-title":"Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease.","volume":"38","author":"Bannerjee","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R27-13-20211004","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000321245","article-title":"Growth hormone treatment in children on chronic glucorticoid therapy.","volume":"20","author":"Savage","year":"2011","journal-title":"Endocr Dev"},{"key":"R28-13-20211004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2265.2011.03977.x","article-title":"A preliminary trial of the effect of recombinant human growth hormone on short-term linear growth and glucose homeostasis in children with Crohns disease.","volume":"74","author":"Wong","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R29-13-20211004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPG.0b013e3181c992d6","article-title":"A randomized controlled trial of growth hormone in active pediatric Crohn disease.","volume":"51","author":"Denson","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R30-13-20211004","doi-asserted-by":"crossref","first-page":"c6434","DOI":"10.1136\/bmj.c6434","article-title":"Diagnosis and management of juvenile idiopathic arthritis.","volume":"341","author":"Prince","year":"2010","journal-title":"BMJ"},{"key":"R31-13-20211004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00431-010-1238-z","article-title":"Biologics in childrens autoimmune disorders: efficacy and safety.","volume":"170","author":"Breda","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R32-13-20211004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1546-0096-8-24","article-title":"The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial.","volume":"8","author":"Visvanathan","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"key":"R33-13-20211004","first-page":"779","article-title":"Growth reconstitution in juvenile idiopathic arthritis treated with etanercept.","volume":"21","author":"Schmeling","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R34-13-20211004","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2005.047225","article-title":"Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.","volume":"65","author":"Tynjala","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R35-13-20211004","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/keq123","article-title":"Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis.","volume":"49","author":"Billiau","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R36-13-20211004","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/art.27682","article-title":"Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.","volume":"62","author":"Giannini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R37-13-20211004","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"R39-13-20211004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1185\/03007995.2010.547575","article-title":"Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohns disease in children: REACH open-label extension.","volume":"27","author":"Hyams","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R40-13-20211004","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1440-1746.2009.06195.x","article-title":"Infliximab improves inflammation and anthropometric measures in pediatric Crohns disease.","volume":"25","author":"Sinitsky","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R41-13-20211004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MPG.0b013e3181edd797","article-title":"Improvement in growth of children with Crohn disease following anti-TNF-alpha therapy can be independent of pubertal progress and glucocorticoid reduction.","volume":"52","author":"Malik","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201202000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:02:27Z","timestamp":1715954547000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201202000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32834ed61f","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}